Fen Wang, Dan Wang, Li-Yue Sun, Shubin Wang. "Optimal subsequent-line strategies for
                    <i>EGFR</i>
                    -mutant NSCLC after TKI progression: A systematic review and network meta-analysis.." Journal of Clinical Oncology (2026). https://doi.org/10.1200/jco.2026.44.16_suppl.e20506